Negative symptoms and concordant impairments in attention in schizophrenia: Associations with social functioning, hope, self-esteem and internalized stigma

Schizophrenia Research

Volumn 110, Issue 1-3, 2009, Pages 165-172

  Lysaker, Paul H ^a,b   Vohs, Jenifer L ^c   Tsai, Jack ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Attention; Negative symptoms; Neurocognition; Positive symptoms; Recovery; Schizoaffective disorder; Schizophrenia; Self esteem; Social function; Stigma

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION DISTURBANCE; CLINICAL ASSESSMENT; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HOPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TASK; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE INDEX; RECOGNITION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF ESTEEM; SOCIAL INTERACTION; STIGMA; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SOCIAL BEHAVIOR; STEREOTYPING;

EID: 67349189157     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.01.015     Document Type: Article

References (58)

1. Andreasen N.C., Flaum M., Swayze V.W., Tyrrell G., and Arndt S. Positive and negative symptoms in schizophrenia: a critical reappraisal. Arch. Gen. Psychiatry 47 (1990) 615-621
2. Asarnow R.F., and MacCrimmon D.J. Span of apprehension deficits during the post-psychotic stages of schizophrenia: a replication and extension. Arch. Gen. Psychiatry 38 (1981) 1006-1011
3. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., and Lindenmayer J.P. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale. Psychiatry Res. 52 (1994) 295-303
4. Bell M., Bryson G., Greig T., Corcoran C., and Wexler B.E. Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance. Arch. Gen. Psychiatry 58 8 (2001) 763-768
5. Berman I., Viegner B., Merson A., Allan E., Pappas D., and Green A.I. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr. Res. 25 (1997) 1-10
6. Bleuler E. Dementia Praecox or the Group of Schizophrenias (1950), International UP, New York
7. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., and Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am. J. Psychiatry 163 (2006) 418-425
8. Bozikas V.P., Kosmidis M.H., Kioperlidou K., and Karavatos A. Relationship between psychopathology and cognitive functioning in schizophrenia. Compr. Psychiatry 45 (2004) 392-400
9. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 32 (2006) 396-400
10. Buchanan R.W., Strauss M.E., Breier A., Kirkpatrick B., and Carpenter W.T. Attentional impairments in deficit and nondeficit forms of schizophrenia. Am. J. Psychiatry 154 (1997) 363-370
11. Buckley P.F., and Stahl S.M. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?. Acta Psychiatr. Scand. 115 (2007) 93-100
12. Carpenter W.T., Bartko J.J., Carpenter C.L., and Strauss J.S. Another view of schizophrenia subtypes: a report from the international pilot study of schizophrenia. Arch. Gen. Psychiatry 33 (1976) 508-516
13. Chen W.J., Kiu S.K., Chang C., Lien Y., Chang Y., and Hwu H. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am. J. Psychiatry 155 (1998) 1214-1220
14. Cohen A.S., and Docherty N.M. Deficit versus negative syndrome in schizophrenia: prediction of attentional impairment. Schizophr. Bull. 30 (2004) 827-835
15. Cohen A.S., Saperstein A.M., Gold J.M., Kirkpatrick B., Carpenter W.T., and Buchanan R.W. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr. Bull. 33 5 (2007) 1201-1212
16. Conners C.K. Conners' Continuous Performance Test (CPT II) (2002), Multi-Health Systems, New York
17. Corin E., and Lauzon G. Positive withdrawal and the quest for meaning: the reconstruction of experience among schizophrenics. Psychiatry 55 (1992) 266-278
18. Cornblatt B., Obuchowski M., Schnur D.B., and O'Brien J.D. Attention and clinical symptoms in schizophrenia. Psychiatr. Q. 68 (1997) 343-359
19. Crow T.J. Molecular pathology of schizophrenia: more than one disease process?. Br. Med. J. 280 (1980) 66-68
20. Dillon W.R., and Goldstein M. Multivariate Analysis: Methods and Applications (1984), John Wiley & Sons, New York, New York
21. Earnst K.S., and Kring A.M. Construct validity of negative symptoms: an empirical and conceptual review. Clin. Psychol. Rev. 17 (1997) 167-189
22. Foussias G., and Remington G. Negative symptoms in schizophrenia: Avolition and Occam's razor. Schizophr. Bull. (2008) 1-11
23. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 153 (1996) 321-330
24. Greenwood K.E., Landau S., and Wykes T. Negative symptoms and specific cognitive impairments as combined targets for improved functional outcome within cognitive remediation therapy. Schizophr. Bull. 31 4 (2005) 910-921
25. Harvey P.D., Koren D., Reichenberg A., and Bowie. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 32 (2006) 250-258
26. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test Manual: Revised and Expanded (1993), Psychological Assessment Resources, Inc., Odessa
27. Heinrichs D.W., Hanlon T.E., and Carpenter W.T. The Quality of Life Scale: an instrument for assessing the schizophrenic deficit syndrome. Schizophr. Bull. 10 (1984) 388-396
28. Hughes C., Kumari V., Soni W., Das M., Binneman B., Drozd S., et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr. Res. 59 2 (2002) 137-146
29. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987) 261-276
30. Kirkpatrick B., Buchanan R.W., Ross D., and Carpenter W.T. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 58 2 (2001) 165-171
31. Lees Roitman S.E., Keefe R.S.E., Harvey P.D., Siever L.J., and Mohs R.C. Attentional and eye tracking deficits correlate with negative symptoms. Schizophr. Res. 26 (1997) 139-146
32. Levin E.D., Wilson W., Rose J.E., and McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15 (1996) 429-436
33. Lysaker P.H., and Bell M.D. Prominent negative symptoms and work performance in schizophrenia. Acta Psychiatr. Scand. 91 (1995) 205-208
34. Lysaker P.H., Davis L.W., and Lysaker J.T. Enactment in schizophrenia: capacity for dialogue and the experience of the inability to commit to action. Psychiatry 69 (2006) 81-93
35. Lysaker P.H., Buck K.D., and Ringer J. The recovery of metacognitive capacity in schizophrenia across thirty two months of individual psychotherapy: a case study. Psychother. Res. 17 (2007) 713-720
36. Lysaker P.H., Tsai J., Yanos P., and Roe D. Associations of multiple domains of self-esteem with four dimensions of stigma in schizophrenia. Schizophr. Res. 98 (2008) 194-200
37. Milev P., Ho B.-C., Arndt S., and Andreason N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 162 (2005) 495-506
38. Mirsky A.F., Ingraham L.J., and Kugelmass S. Neuropsychological assessment of attention and its pathology in the Israeli cohort. Schizophr. Bull. 21 (1995) 193-204
39. Möller H.J. Clinical evaluation of negative symptoms in schizophrenia. Eur. Psychiatr. 22 (2007) 380-386
40. Nieuwenstein M.R., Aleman A., and de Haan E.H.F. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. J. Psychiatr. Res. 35 (2001) 119-125
41. Nuechterlein K.H. Vigilance in schizophrenia and related disorders. In: Steinhauer S.R., Gruzelier J.H., and Zubin J. (Eds). Handbook of Schizophrenia Neuropsychology, Psychophysiology, and Information Processing vol 5 (1991), Elsevier, New York 397-433
42. Nuechterlein K.H., Edell W.S., Norris M., and Dawson M.E. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr. Bull. 12 3 (1986) 408-426
43. Nuechterlein K.H., Dawson M.E., Ventura J., Gitlin M., Subotnik K.L., Snyder K.S., et al. The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr. Scand., Suppl. 382 (1994) 58-64
44. O'Brien E.J., and Epstein S. MSEI: The Multidimensional Self-esteem Inventory Professional Manual (1998), Psychological Assessment Resources, Inc., Lutz FL
45. Rector N.A., Beck A.T., and Stolar N. The negative symptoms of schizophrenia: a cognitive perspective. Can. J. Psychiatry 50 (2005) 247-257
46. Riccio C.A., Reynolds C.R., Lowe P., and Moore J.J. The continuous performance test: a window on the neural substrates for attention?. Arch. Clin. Neuropsychol. 17 3 (2002) 235-272
47. Ritsher J.B., and Phelan J.C. Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res. 129 (2004) 257-265
48. Ritsher J.B., Otilingam P.G., and Grajales M. Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiatry Res. 121 (2003) 31-49
49. Salvatore G., Dimaggio G., and Lysaker P.H. An inter-subjective perspective on negative symptoms of schizophrenia: implications of simulation theory. Cogn. Neuropsychiatry 12 (2007) 144-164
50. Sensky T., Turkington D., Kingdom D., Scott J.L., Scott J., Siddle R., Carrol M., and Barnes T.R.E. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch. Gen. Psychiatry 57 (2000) 165-172
51. Smith R.C., Warner-Cohen J., Matute M., Butler E., Kelly E., Vaidhyanathaswamy S., and Khan A. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 31 (2006) 637-643
52. Spitzer R., Williams J., Gibbon M., and First M. Structured Clinical Interview for DSM IV Biometrics Research: New York (1994)
53. Strauss M.E. Relations of symptoms to cognitive deficits in schizophrenia. In: Shore D. (Ed). Special report: Schizophrenia 1993 (1993), National Institute of Mental Health, Rockville, Maryland 41-57
54. Strauss M.E., Buchanan R.W., and Hale J. Relations between attentional deficits and clinical symptoms in schizophrenia outpatients. Psychiatry Res. 74 (1993) 205-213
55. Swets J.A. The relative operating characteristic in psychology. Science 182 (1973) 990-1000
56. Tandon R., DeQuardo J.R., Taylor S.F., McGrath M., Jibson M., Eiser A., and Goldman M. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr. Res. 45 3 (2000) 191-201
57. Villalta-Gil V., Vilaplana M., Ochoa S., Haro J.M., Dolz M., Usall J., and Cervilla J. Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?. Schizophr. Res. 87 (2006) 246-253
58. Wright E.R., Gronfein W.P., and Owens T.J. Deinstitutionalization, social rejection and the self esteem of former mental patients. J. Health Soc. Behav. 41 (2000) 68-90